JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.96B |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.61B |
| 4 |
UnitedHealth
UNH
|
+$1.1B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.25B |
| 2 |
Centene
CNC
|
+$827M |
| 3 |
Amazon
AMZN
|
+$791M |
| 4 |
Texas Instruments
TXN
|
+$716M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$569M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.62% |
| 2 | Healthcare | 12.48% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4601
Cadre Holdings
CDRE
$1.46B
| $252K | ﹤0.01% |
10,467
-44,621
| -81% | -$1.09M |
|
4602
Esquire Financial Holdings
ESQ
$1.55B
| $251K | ﹤0.01% |
6,684
-18
| -0.3% | -$670 |
|
4603
Mitsubishi UFJ Financial
MUFG
$260B
| $251K | ﹤0.01% |
55,888
-816
| -1% | -$4.25K |
|
|
BLTE
4604
Belite Bio
BLTE
$6.56B
| $250K | ﹤0.01% |
+7,400
| New | +$256K |
|
|
IGMS
4605
DELISTED
IGM Biosciences
IGMS
| $250K | ﹤0.01% |
10,992
+1,031
| +10% | +$20.8K |
|
4606
i3 Verticals
IIIV
$294M
| $250K | ﹤0.01% |
12,480
-5,385
| -30% | -$131K |
|
|
RJET
4607
Republic Airways Holdings
RJET
$952M
| $249K | ﹤0.01% |
10,046
+197
| +2% | +$6.75K |
|
4608
ProShares UltraPro Short S&P 500
SPXU
$380M
| $249K | ﹤0.01% |
+555
| New | +$190K |
|
|
TDAY
4609
USA Today Co
TDAY
$1.03B
| $248K | ﹤0.01% |
161,903
+4,722
| +3% | +$11.5K |
|
4610
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.38B
| $248K | ﹤0.01% |
10,752
-2,454
| -19% | -$58.5K |
|
4611
Kiniksa Pharmaceuticals
KNSA
$5.99B
| $248K | ﹤0.01% |
19,288
+1,115
| +6% | +$12.7K |
|
4612
Stoneridge
SRI
$205M
| $248K | ﹤0.01% |
14,615
+414
| +3% | +$7.78K |
|
|
IMGO
4613
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $248K | ﹤0.01% |
16,498
+976
| +6% | +$15.8K |
|
4614
Accel Entertainment
ACEL
$1.01B
| $247K | ﹤0.01% |
31,715
-40,757
| -56% | -$414K |
|
|
QUOT
4615
DELISTED
Quotient Technology Inc
QUOT
| $247K | ﹤0.01% |
106,905
-8,102
| -7% | -$19.9K |
|
4616
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.98B
| $246K | ﹤0.01% |
4,080
-85
| -2% | -$5.61K |
|
|
BSAQ
4617
DELISTED
Black Spade Acquisition Co
BSAQ
| $245K | ﹤0.01% |
25,000
-124,926
| -83% | -$1.22M |
|
4618
Algoma Steel
ASTL
$452M
| $244K | ﹤0.01% |
+37,837
| New | +$338K |
|
4619
Ceco Environmental
CECO
$4.66B
| $244K | ﹤0.01% |
27,548
-3,370
| -11% | -$28.9K |
|
4620
Centrus Energy
LEU
$3.79B
| $244K | ﹤0.01% |
5,969
+228
| +4% | +$8.77K |
|
4621
TETRA Technologies
TTI
$1.27B
| $244K | ﹤0.01% |
68,023
+1,467
| +2% | +$5.78K |
|
4622
Ducommun
DCO
$3.13B
| $243K | ﹤0.01% |
6,116
+131
| +2% | +$5.82K |
|
4623
iShares US Energy ETF
IYE
$1.82B
| $243K | ﹤0.01% |
6,185
-14,249
| -70% | -$585K |
|
4624
Crescent Energy
CRGY
$4.03B
| $242K | ﹤0.01% |
17,995
-25,033
| -58% | -$367K |
|
4625
Workhorse Group
WKHS
$33.3M
| $242K | ﹤0.01% |
28
+1
| +4% | +$9.72K |
|
Similar funds
JP Morgan Chase's Q3 2022 Portfolio in Review
As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q3 2022 filing shows 557 new, 2,573 increased, 2,583 reduced and 516 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
- JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
- JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
- JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
- JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
- JP Morgan Chase opened 557 new positions and closed 516 in Q3 2022.
- JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.